
结论很直接:这个市场不值得进入。 不是因为完全没有利润,而是因为新品牌胜率太低、同质化太强,已经进入高压竞争和明显价格挤压区;用户预算50万人民币只能覆盖少数单品的前期启动,但不足以支撑这种需要持续投放和差异化的赛道。
市场数据说明问题很清楚:新发布产品里只有16.67%盈利,按新品牌看也只有20%,而且近几次新增里失败占绝对多数;时间上看,2025年10月到2026年5月的新发大多落在“其他/未跑通”,没有形成持续改善。利润表现也不健康,已知新产品主要集中在26.53%~27.43%,没有出现大量40%+高利润款,说明不是蓝海,而是靠压价和投放争流量。品牌层面,KYNOVEX只有1个赚钱款 B0H26GYQBM,3个新发里有1个盈利;Pdoo 3个新发全亏,Colgate 的新发 B0GP85WC8J 也没跑通。真正赚钱的样本里,Colgate 的 B0C4FHSGH6、B0DP557BPL 都是706条评论级别的强势老品牌,属于大品牌打法,不是小商家模板;而唯一的新品牌盈利款 KYNOVEX 的 B0H26GYQBM,售价£169.54,月销50,月营收£8,477,利润率30.22%,早期投入约$41,412,说明它靠的是高预算+功能差异化,不是低成本复制。相反,Pdoo 的 B0H1QGLLHZ、B0H1KQ8SWG 都是同质化LED美白套装,分别£49.11和£59.99,却都失败,显示这个市场对普通小卖家极不友好。
These products have successfully captured market share and are profitable. Their design and features are suggested for your investment, based on market competition, saturation, and demand.
Green indicates better success rate, red indicates poorer success rate. If you are a new brand, focus on the left side; if you are an old brand, focus on the right side.
这不是一个适合入场的市场。 用户预算50万人民币只能覆盖少数入门级ASIN的前期铺货和投放,但市场里已经出现明显的价格与竞争挤压:整体可判定盈利的样本只有33.33%,新品盈利率只有16.67%,而新品牌新品盈利率仅20%,新品牌新品不盈利率高达80%;更关键的是,样本里旧品牌新品不盈利率100%,说明连大品牌推新也在承压,市场不是蓝海而是高压竞争区。
Some categories may not originally require certain certificates for entry; however, some products may target specific features (e.g. Bluetooth) or customers (e.g. children), and additional certificates may be required in the target marketplace (e.g. FCC, CPC).
Alternative solutions may pose a risk to your investment in certain markets.
这个市场不适合进入,结论很直接:已经是价格战+高风险的挤压市场。 样本里可识别利润产品只有33.33%,新品牌新品盈利率只有16.67%,而新品牌新品不盈利率高达80%;更关键的是,2025~2026的新释放几乎都在亏损或不活跃,说明新进入者并没有稳定跑出来。
这个市场不适合进入,结论很明确:新品牌已经进入了价格战/高压竞争区,且对小企业尤其不友好。 目前可识别的新品牌里,KYNOVEX 只有 1 个盈利产品、1 个亏损产品,品牌成功率只有 50%;但更关键的是,新品里能稳定赚钱的只有 B0H26GYQBM 一个,其他 5 个新产品都未达标,说明可复制的成功样本极少,且市场并不是靠“普通上架”就能赢的。
证据非常直接:利润分布几乎都卡在 20%~30%,没有任何新产品达到 40%+ 的强利润带。 新产品中,30%~40% 只有 1 个(B0H26GYQBM),20%~30% 只有 2 个,其余 83.33% 都落在“其他/无足够数据”里;按已知利润样本看,成功的只有 1 个,意味着已知成功率并不高,而且高利润并没有形成健康扩散。B0H26GYQBM 本身卖到 £169.54、月销 50、月利润 £2561.75、利润率 30.22%,靠的是基于旧款重做 + 功能差异化:把美白和脱敏修复合并成套装,面向“敏感牙+在家美白”人群,这不是简单复制能做到的;它的早期投入高达约 $41,412,其中广告约 $9,504,说明这类成功更像是“高投入的新品牌打法”,不是小生意低预算打法。更糟的是,亏损/失败新产品里,Pdoo、KYNOVEX、Colgate 都有代表款,说明失败并不只发生在新手,也发生在老牌和新品牌的新品上,竞争压力很高。
对两类卖家都要说清楚:大品牌可以尝试,但要按高预算、强研发、强品牌的思路做;小企业不建议进入,除非你能做出明显差异化且接受高推广成本。 大品牌可参考的样本是 B0H26GYQBM(KYNOVEX)以及 Colgate 的两个 20%+ 利润款 B0C4FHSGH6、B0DP557BPL,但它们都不代表“轻松进入”,而是代表需要品牌力、预算和持续投放。小企业这边,没有看到任何“<300 reviews/year 的真实低评价压力下仍稳定赢”的明确案例,反而高利润样本明显带有差异化和更重投放痕迹;如果你要进场,必须把它当成高预算、强差异化、长期烧钱项目来做,否则大概率被低利润和竞争挤压掉。
All products profit ratio distribution, including all products. For products with insufficient sales or missing profit ratio data, they will be categorized into other rows. This distribution included products that cannot determine the release date.
This are the profit ratios of all new products. There are products without sufficient sales, no more than 100pcs in 3 months, or no profit ratio data, or just released. Those will be considered as 'other'
Most profitable products ranked by profit value. Only includes products with positive profitability and active sales, regardless of release date.
![]() | B0H26GYQBM | KYNOVEX | 2026-05-18 | Yes | £169.54 | 50pcs | £8477.0 | 30.22% | £2561.75 |
![]() | B0C4FHSGH6 | Colgate | 2023-05-05 | Yes | £43.5 | 100pcs | £4350.0 | 24.37% | £1060.1 |
![]() | B0DP557BPL | Colgate | 2024-11-27 | Yes | £66.1 | 50pcs | £3305.0 | 27.51% | £909.21 |
Most profitable new products ranked by profit value. Only includes newly released products with positive profitability and active sales.
![]() | B0H26GYQBM | KYNOVEX | 2026-05-18 | Yes | £169.54 | 50pcs | £8477.0 | 30.22% | £2561.75 |
这个市场不适合进入,结论很明确:旧品牌在吃肉,新品牌大多在亏,已经是高竞争、低容错的市场。 现有数据里,新产品成功率只有16.67%,而新品牌自己看成功率只有20%,但真正能算“小品牌正常成功”的几乎没有;唯一赚钱的新品牌 KYNOVEX 只靠 B0H26GYQBM 一款打穿,靠的是在旧爆款基础上做功能差异化,而不是从零创新。
What is the ratio of profitable products
What is the ratio of different brands owning all profitable new products
What is the ratio of different brands owning all nonprofitable new products
这不是一个适合现在进入的市场:新品牌只有2个、老品牌2个,但新发布里只有16.67%成功,80%是失败,新品牌新发成功率只有20%,而且近两次新品牌尝试全部失败,说明竞争正在变硬而不是变容易。 目前真正能跑出来的只有 KYNOVEX 的 B0H26GYQBM(45条评论、£8,477月收入、30.2%利润率、早期总投入约£41,412),其余新品牌 Pdoo 的 B0H1QGLLHZ、B0H1KQ8SWG 以及 KYNOVEX 的老款 B0G6K87162 都没跑通;老品牌 Colgate 只有靠 B0GP85WC8J 这条新发也失败了,说明这个赛道不是“新手友好”,而是被大品牌和强投放挤压的高门槛市场。
证据很直接:市场里可见的可盈利样本只占33.33%,但最近新发布的利润区间里,5个里只有1个达到30%+利润率,其余4个都没达到盈利标准;按时间看,2025年10月、2026年2月、2026年5月的新增里,失败样本持续出现,最近并没有变得更容易。KYNOVEX 的成功不是低预算小卖家模式,而是高投入+差异化功能:把美白和脱敏修复打包,且单个成功品的早期投入已到£41k级别;反过来,Pdoo 的两个新发都失败,价格在£49.11和£59.99,却因为同质化太强没有跑出来。Colgate 的 B0C4FHSGH6 和 B0DP557BPL 这类老品牌成功样本都带有品牌力和旧链接基础,评论数 706,明显不是小商家可复制的路径;同时,B0H26GYQBM 45条评论就已经做到£8,477月收入,属于真实可见的强样本,但它依赖的不是低评论自然增长,而是明显的投放和产品差异化,不适合预算有限的普通新卖家照搬。
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
| Time/Profit% | x < -10.0% | -10.0% <= x < 0.0% | 0.0% <= x < 10.0% | 10.0% <= x < 20.0% | 20.0% <= x < 30.0% | 30.0% <= x < 40.0% | x >= 40.0% | other |
|---|---|---|---|---|---|---|---|---|
| 2022 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2024 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 |
| 2026 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 3 |
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
| Time/Profit% | x < -10.0% | -10.0% <= x < 0.0% | 0.0% <= x < 10.0% | 10.0% <= x < 20.0% | 20.0% <= x < 30.0% | 30.0% <= x < 40.0% | x >= 40.0% | other |
|---|---|---|---|---|---|---|---|---|
| 2025/7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025/8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025/9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025/10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 |
| 2025/11 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025/12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| 2026/3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/5 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 2 |
| 2026/6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |